Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds

Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The globa...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Andrea Barbieri, Rodrigues, Alex Miranda, Batista, Mariane Pereira, Munhoz, Sidney, Hueb, Marcia, Fontes, Cor Jesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2014
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155856/
https://www.ncbi.nlm.nih.gov/pubmed/25004145
http://dx.doi.org/10.1590/0074-0276130563
_version_ 1782333644080152576
author Barros, Andrea Barbieri
Rodrigues, Alex Miranda
Batista, Mariane Pereira
Munhoz, Sidney
Hueb, Marcia
Fontes, Cor Jesus
author_facet Barros, Andrea Barbieri
Rodrigues, Alex Miranda
Batista, Mariane Pereira
Munhoz, Sidney
Hueb, Marcia
Fontes, Cor Jesus
author_sort Barros, Andrea Barbieri
collection PubMed
description Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported.
format Online
Article
Text
id pubmed-4155856
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-41558562014-09-11 Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds Barros, Andrea Barbieri Rodrigues, Alex Miranda Batista, Mariane Pereira Munhoz, Sidney Hueb, Marcia Fontes, Cor Jesus Mem Inst Oswaldo Cruz Short Communications Antimony compounds are the cornerstone treatments for tegumentary leishmaniasis. The reactivation of herpes virus is a side effect described in few reports. We conducted an observational study to describe the incidence of herpes zoster reactivation during treatment with antimony compounds. The global incidence of herpes zoster is approximately 2.5 cases per 1,000 persons per month (or 30 cases per 1,000 persons per year). The estimated incidence of herpes zoster in patients undergoing antimony therapy is higher than previously reported. Instituto Oswaldo Cruz, Ministério da Saúde 2014-07-03 2014-07 /pmc/articles/PMC4155856/ /pubmed/25004145 http://dx.doi.org/10.1590/0074-0276130563 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Short Communications
Barros, Andrea Barbieri
Rodrigues, Alex Miranda
Batista, Mariane Pereira
Munhoz, Sidney
Hueb, Marcia
Fontes, Cor Jesus
Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_fullStr Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_full_unstemmed Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_short Varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
title_sort varicella zoster virus reactivation during or immediately following treatment of tegumentary leishmaniasis with antimony compounds
topic Short Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4155856/
https://www.ncbi.nlm.nih.gov/pubmed/25004145
http://dx.doi.org/10.1590/0074-0276130563
work_keys_str_mv AT barrosandreabarbieri varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT rodriguesalexmiranda varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT batistamarianepereira varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT munhozsidney varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT huebmarcia varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds
AT fontescorjesus varicellazostervirusreactivationduringorimmediatelyfollowingtreatmentoftegumentaryleishmaniasiswithantimonycompounds

Ejemplares similares